Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| CHAI | PRESS-RELEASE | bearish | 6/10 | Core AI Holdings reported FY2025 revenue from continuing operations of $55.2M (+58.6% YoY), but a GAAP EPS of -$8.15 mis | May 18, 2026 |
| SHFS | PRESS-RELEASE | mixed | 5/10 | Safe Harbor Financial reported Q1 2026 revenue of ~$2.0M (+2.2% YoY) and a net loss of ~$1.8M (vs ~$0.8M loss in Q1 2025 | May 18, 2026 |
| STEX | PRESS-RELEASE | neutral | 2/10 | Streamex announced the second monthly yield distribution for its gold-backed tokenized security GLDY, distributing 8.267 | May 18, 2026 |
| BWAY | PRESS-RELEASE | neutral | 4/10 | BrainsWay announced a strategic minority investment of $1.5M (with potential $1.5M in milestone-based investments) in Ho | May 18, 2026 |
| FGNX | PRESS-RELEASE | neutral | 2/10 | FG Nexus declared a $0.50 per share quarterly cash dividend on its 8.00% Cumulative Preferred Stock, Series A (FGNXP), m | May 18, 2026 |
| IINN | PRESS-RELEASE | bullish | 5/10 | Inspira Technologies received a $580,000 commercial purchase order from NYU Langone Hospital for its FDA-cleared ART100 | May 18, 2026 |
| ATEX | PRESS-RELEASE | bullish | 5/10 | Anterix and Lynk Global received FCC approval for an experimental license to test satellite D2D integration in Anterix's | May 18, 2026 |
| DUOT | PRESS-RELEASE | mixed | 6/10 | Duos Technologies reported Q1 2026 revenue of $2.72M (down 45% YoY) and a net loss of $3.49M ($-0.15 EPS), missing the $ | May 18, 2026 |
| CRVO | PRESS-RELEASE | mixed | 6/10 | CervoMed reported Q1 2026 EPS of -$0.86, beating consensus of -$0.98 by 12.2%, but net loss widened to -$8.0M from -$4.9 | May 18, 2026 |
| NGEN | PRESS-RELEASE | bearish | 6/10 | NervGen Pharma reported Q1 2026 net loss of $1.7M ($0.09 diluted EPS) vs consensus $-0.07, a 28.6% miss on the Street-qu | May 18, 2026 |
| AMWL | PRESS-RELEASE | bullish | 6/10 | Amwell announced results from a large NIH-funded randomized trial published in Nature Human Behaviour, showing SilverClo | May 18, 2026 |
| REGN | PRESS-RELEASE | neutral | 4/10 | Regeneron announced a strategic research collaboration with Parabilis Medicines to discover Antibody-Helicon Conjugates | May 18, 2026 |
| QUCY | PRESS-RELEASE | neutral | 3/10 | Quantum Cyber announced participation as an exhibitor at SOF Week 2026, a premier defense convention. The event provides | May 18, 2026 |
| NRXP | PRESS-RELEASE | bullish | 6/10 | NRx Pharmaceuticals reported Q1 2026 EPS of -$0.04, beating consensus of -$0.13 by 69.2%, with net loss narrowing to $1. | May 18, 2026 |
| IREN | PRESS-RELEASE | neutral | 3/10 | IREN acquired Awaken, its external marketing agency, bringing the team in-house to support AI Cloud growth and global br | May 18, 2026 |
| BRC | PRESS-RELEASE | mixed | 7/10 | Brady Corp (BRC) reported Q3 FY2026 GAAP diluted EPS of $1.21, missing the $1.34 consensus by 9.7%, but the headline sto | May 18, 2026 |
| DSGN | PRESS-RELEASE | bullish | 8/10 | Design Therapeutics announced positive Phase 1/2 RESTORE-FA data for DT-216P2 in Friedreich ataxia, showing dose-depende | May 18, 2026 |
| CNTX | PRESS-RELEASE, 8-K | bullish | 7/10 | Context Therapeutics amended its license agreement with BioAtla for CT-202, buying out all future milestone and royalty | May 18, 2026 |
| GNK | PRESS-RELEASE | bullish | 7/10 | Genco Shipping & Trading issued a press release urging shareholders to vote for its six director nominees on the WHITE p | May 18, 2026 |
| CATX | PRESS-RELEASE | neutral | 3/10 | Perspective Therapeutics announced first patient dosing in two new cohorts of its Phase 1/2a trials for [212Pb]VMT-α-NET | May 18, 2026 |
| SACH | PRESS-RELEASE | mixed | 7/10 | Sachem Capital announced a definitive agreement for IRG to contribute 98 industrial assets, creating a combined industri | May 18, 2026 |
| EH | PRESS-RELEASE | neutral | 4/10 | EHang issued a press release directing investors to a Q&A page regarding corrected unaudited financials for 2025 filed v | May 18, 2026 |
| FLX | PRESS-RELEASE | bullish | 5/10 | BingEx (FLX) announced that its subsidiary signed a strategic investment agreement with Hangzhou Low-Altitude Industry D | May 18, 2026 |
| IQ | PRESS-RELEASE | bearish | 7/10 | iQIYI reported a GAAP net loss of RMB294.6M for Q1 2026, swinging from a net profit of RMB182.1M a year ago as total rev | May 18, 2026 |
| VEON | PRESS-RELEASE | neutral | 4/10 | VEON subsidiary VEON MidCo B.V. is pursuing a dual-tranche senior unsecured notes offering (5-year NC2 and 7 NC3) alongs | May 18, 2026 |
| NIU | PRESS-RELEASE | neutral | 5/10 | NIU reported Q1 2026 revenue of RMB 909.5M (+33.4% YoY), driven by strong China e-scooter sales (+41.6%), but net loss w | May 18, 2026 |
| BTM | PRESS-RELEASE | bearish | 9/10 | Bitcoin Depot filed for voluntary Chapter 11 bankruptcy to wind down operations and sell assets, citing an unsustainable | May 18, 2026 |
| RCEL | PRESS-RELEASE | neutral | 1/10 | AVITA Medical announced it will host a conference call on May 20, 2026 to discuss its Q1 2026 results. | May 17, 2026 |
| LIF | PRESS-RELEASE | bullish | 5/10 | Life360 announced a $225M multi-year share repurchase program to offset dilution from stock-based compensation. The prog | May 17, 2026 |
| DSGN | PRESS-RELEASE | bullish | 8/10 | Design Therapeutics will announce Phase 1/2 RESTORE-FA trial data for DT-216P2 in Friedreich's ataxia on May 18, 2026. T | May 17, 2026 |